Nabriva Therapeutics (NBRV) Insider Trading & Ownership → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free NBRV Stock Alerts Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsSocial Media Nabriva Therapeutics (NASDAQ:NBRV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.63%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$117,630.00Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$2,376.72 Get NBRV Insider Trade Alerts Want to know when executives and insiders are buying or selling Nabriva Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBRV Insider Buying and Selling by Quarter Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. Nabriva Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2022Charles A Rowland JrDirectorSell8,496$0.17$1,444.32 12/28/2021Theodore R SchroederCEOBuy100,000$0.57$57,000.00 12/27/2021J. Christopher NaftzgerGeneral CounselBuy7,000$0.59$4,130.00 9/14/2021Theodore R. SchroederCEOBuy50,000$1.13$56,500.00 8/2/2021Stephen W. WebsterDirectorSell777$1.20$932.40 (Data available from 1/1/2013 forward) NBRV Insider Trading Activity - Frequently Asked Questions Who is on Nabriva Therapeutics's Insider Roster? The list of insiders at Nabriva Therapeutics includes Charles A Rowland Jr, J. Christopher Naftzger, Stephen W. Webster, Theodore R Schroeder. Learn more on insiders at NBRV. What percentage of Nabriva Therapeutics stock is owned by insiders? 1.63% of Nabriva Therapeutics stock is owned by insiders. Learn more on NBRV's insider holdings. Which Nabriva Therapeutics insiders have been selling company stock? The following insider sold NBRV shares in the last 24 months: Charles A Rowland Jr ($1,444.32). How much insider selling is happening at Nabriva Therapeutics? Insiders have sold a total of 8,496 Nabriva Therapeutics shares in the last 24 months for a total of $1,444.32 sold. More Insider Trading Tools from MarketBeat Related Companies: NRx Pharmaceuticals Insider Transactions Bolt Biotherapeutics Insider Transactions Ocuphire Pharma Insider Transactions Checkpoint Therapeutics Insider Transactions BriaCell Therapeutics Insider Transactions Korro Bio Insider Transactions Regulus Therapeutics Insider Transactions Unicycive Therapeutics Insider Transactions Milestone Pharmaceuticals Insider Transactions Cara Therapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders Are Buying That Analysts LoveInsider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale This page (NASDAQ:NBRV) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nabriva Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.